Diagnostic chain Metropolis Healthcare on Monday said it will acquire Core Diagnostics for Rs 247 crore. The company's board has approved the acquisition of 100 per cent stake in Core Diagnostics from ...
Hosted on MSN
Metropolis Healthcare acquires Core Diagnostics for ₹247 crore, expands north, east footprint
India’s second largest pathology lab chain Metropolis Healthcare Ltd on Monday announced that it had acquired a 100% stake in Delhi-NCR headquartered Core Diagnostics, a prominent player in India’s ...
SRM Institute of Science and Technology (SRMIST) has signed a Memorandum of Understanding (MoU) with CORE Diagnostics, a global leader in cancer diagnostics and genomic testing. With cancer care ...
Abbott ABT, a global leader in healthcare solutions, recently achieved a significant milestone with the FDA approval of its cutting-edge Alinity h-series hematology system. This approval is poised to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results